Chaetoglobosin A structure
|
Common Name | Chaetoglobosin A | ||
|---|---|---|---|---|
| CAS Number | 50335-03-0 | Molecular Weight | 528.63900 | |
| Density | 1.3 g/cm3 | Boiling Point | 789.7ºC at 760 mmHg | |
| Molecular Formula | C32H36N2O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 431.4ºC | |
Use of Chaetoglobosin AChaetoglobosin A, the active principle within the extract of Penicillium aquamarinium, is a member of the cytochalasan family. Chaetoglobosin A preferentially induces apoptosis. Chaetoglobosin A targets filamentous actin in CLL cells and thereby induces cell-cycle arrest and inhibits membrane ruffling and cell migration[1]. |
| Name | chaetoglobosin A |
|---|---|
| Synonym | More Synonyms |
| Description | Chaetoglobosin A, the active principle within the extract of Penicillium aquamarinium, is a member of the cytochalasan family. Chaetoglobosin A preferentially induces apoptosis. Chaetoglobosin A targets filamentous actin in CLL cells and thereby induces cell-cycle arrest and inhibits membrane ruffling and cell migration[1]. |
|---|---|
| Related Catalog | |
| Target |
Filamentous actin[1] |
| References |
| Density | 1.3 g/cm3 |
|---|---|
| Boiling Point | 789.7ºC at 760 mmHg |
| Molecular Formula | C32H36N2O5 |
| Molecular Weight | 528.63900 |
| Flash Point | 431.4ºC |
| Exact Mass | 528.26200 |
| PSA | 111.79000 |
| LogP | 4.16120 |
| Index of Refraction | 1.651 |
| InChIKey | OUMWCYMRLMEZJH-ZDSWJECVSA-N |
| SMILES | CC1=CC(C)CC=CC2C3OC3(C)C(C)C3C(Cc4c[nH]c5ccccc45)NC(=O)C23C(=O)C=CC(=O)C1O |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| RIDADR | NONH for all modes of transport |
|---|
|
Exploiting the cytoskeletal filaments of neoplastic cells to potentiate a novel therapeutic approach.
Biochim. Biophys. Acta 1846(2) , 599-616, (2014) Although cytoskeletal-directed agents have been a mainstay in chemotherapeutic protocols due to their ability to readily interfere with the rapid mitotic progression of neoplastic cells, they are all ... |
|
|
Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cells.
Cancer Lett. 356(2 Pt B) , 418-33, (2015) Adverse side effects and acquired resistance to conventional platinum based chemotherapy have become major impediments in ovarian cancer treatment, and drive the development of more selective anticanc... |
|
|
Chaetoglobosin F, a small molecule compound, possesses immunomodulatory properties on bone marrow-derived dendritic cells via TLR9 signaling pathway.
Immunobiology 218(3) , 292-302, (2013) Chaetoglobosin F (Cha F), a cytochalasan-based alkaloid, was obtained from the EtOAc extract of a solid culture of Chaetomium globosum IFB-E019. Dendritic cells (DCs), the most potent antigen presenti... |
| chaetoglobosins |
| Chaetoglobosin A |
| CHAETOGLOBOSIN A |
| CHAETOGLOBOSIN |
| CHAETOGLOBOSINB |
| 18-dimethyl-,(7s,13e,16s,17e,19r,21e)-ol-3-yl)-1 |
| CHAETOGLOBOSINE |
| (13)cytochalasa-13,17,21-triene-1,20,23-trione,6,7-epoxy-19-hydroxy-10-(1h-ind |
| CHAETOGLOBOSINM |
| CHAETOGLOBOSINL |